Who owns Alamar Biosciences, Inc. (ALMR)? Elite investor 13F holders

2 tracked elite investors reported holding Alamar Biosciences, Inc as of 2026-09-30, including Renaissance Technologies LLC, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

2 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCCommon Stock, par value $0.0001 per shareSHARE2026-09-302026-11-12 00:00:004180048.00 USD122690.000000SharesbuyOriginal filing
D.E. ShawCommon Stock, par value $0.0001 per shareSHARE2026-09-302026-11-16 00:00:00706680.00 USD20742.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown